newsfilter
← Latest News
GlobeNewswire·

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that Impact BioMedical Inc. ("Impact") filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6,